GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Gross Margin %

Abingdon Health (LSE:ABDX) Gross Margin % : 53.03% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Abingdon Health's Gross Profit for the six months ended in Dec. 2023 was £1.28 Mil. Abingdon Health's Revenue for the six months ended in Dec. 2023 was £2.41 Mil. Therefore, Abingdon Health's Gross Margin % for the quarter that ended in Dec. 2023 was 53.03%.


The historical rank and industry rank for Abingdon Health's Gross Margin % or its related term are showing as below:

LSE:ABDX' s Gross Margin % Range Over the Past 10 Years
Min: -126.7   Med: 51.3   Max: 78.05
Current: 57.35


During the past 6 years, the highest Gross Margin % of Abingdon Health was 78.05%. The lowest was -126.70%. And the median was 51.30%.

LSE:ABDX's Gross Margin % is ranked better than
61.14% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.55 vs LSE:ABDX: 57.35

Abingdon Health had a gross margin of 53.03% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Abingdon Health was 0.00% per year.


Abingdon Health Gross Margin % Historical Data

The historical data trend for Abingdon Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Gross Margin % Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Margin %
Get a 7-Day Free Trial 69.04 78.05 35.66 -126.70 51.30

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.90 -216.80 25.92 60.91 53.03

Competitive Comparison of Abingdon Health's Gross Margin %

For the Diagnostics & Research subindustry, Abingdon Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Gross Margin % falls into.



Abingdon Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Abingdon Health's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )=Gross Profit (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=2.1 / 4.045
=(Revenue - Cost of Goods Sold) / Revenue
=(4.045 - 1.97) / 4.045
=51.30 %

Abingdon Health's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1.3 / 2.41
=(Revenue - Cost of Goods Sold) / Revenue
=(2.41 - 1.132) / 2.41
=53.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Abingdon Health  (LSE:ABDX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Abingdon Health had a gross margin of 53.03% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Abingdon Health Gross Margin % Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines